Patrys (ASX:PAB) Purchase Of Business : A$0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Patrys Purchase Of Business?

Patrys's purchase of business for the six months ended in Dec. 2023 was A$0.00 Mil. It means Patrys spent A$0.00 Mil on purchasing business. Patrys's purchase of business for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00 Mil.

Compared with last quarter (A$0.00 Mil in Jun. 2023 ), Patrys spent the same money on purchasing business in Dec. 2023 (A$0.00 Mil).

Patrys Purchase Of Business Historical Data

The historical data trend for Patrys's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Patrys Purchase Of Business Chart

Patrys Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Purchase Of Business

Get a 7-Day Free Trial

Patrys Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Purchase Of Business	Get a 7-Day Free Trial															-	-	-	-	-

Patrys Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Patrys Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Patrys's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Patrys Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Patrys Ltd (ASX:PAB) » Definitions » Purchase Of Business

Comparable Companies

Traded in Other Exchanges

N/A

Address

Level 4, 100 Albert Road, South Melbourne, Melbourne, VIC, AUS, 3205

Website

https://www.patrys.com

Patrys Ltd focuses on the development of natural human antibody-based therapies for the treatment of cancer. The company's product includes Deoxymab 3E10, PAT-SC1, PAT-DX1 PAT-DX1-NP, PAT-DX3, and PAT-LM1. Its main technology is Deoxymab 3E10, a DNA damage repair (DDR) antibody that penetrates live cell nuclei and inhibits key mechanisms of DNA repair in target cancer cells.